July 27, 2017 3:24 AM ET


Company Overview of NanoMedex Pharmaceuticals, Inc.

Company Overview

NanoMedex Pharmaceuticals, Inc. develops technology that enables the direct dispersion or emulsification of oils or water-insoluble liquids in aqueous media. The company offers Microfol, a micro emulsion formulation containing the generic active pharmaceutical ingredient propofol and two IIG listed excipients-sodium caprylate and poloxamer 188, which replaces the macro emulsion components of the reference listed drug and its generic equivalents. Its formulation is applied to a range of drug classes, including chemotherapeutics, anesthetics, anti-infective, anti-inflammatories and arrythmics, immunosuppressants, and vitamins. The company was founded in 2002 and is based in Fitchburg, Wisconsi...

5520 Nobel Drive

Suite 150

Fitchburg, WI 53711

United States

Founded in 2002





Key Executives for NanoMedex Pharmaceuticals, Inc.

President and Executive Officer
Age: 62
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NanoMedex Pharmaceuticals, Inc., please visit www.nanomedex.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.